Maryland
|
001-08443
|
52-0880974
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
19886 Ashburn Road,
|
||
Ashburn, Virginia
|
20147-2358
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(703) 724-3800
|
(Registrant’s telephone number, including area code)
|
Title of each class
|
Trading symbol
|
Name of each exchange on which registered
|
Common stock, $0.001 par value per share
|
TLS
|
The Nasdaq Stock Market LLC
|
Item 2.02. |
Results of Operations and Financial Condition.
|
Item 9.01. |
Financial Statements and Exhibits
|
99.1 |
Press Release, dated March 25, 2021
|
TELOS Corporation
|
||
By:
|
/s/ Michele Nakazawa
|
|
Michele Nakazawa
|
||
Chief Financial Officer
|
|
- |
Full Year 2020 Revenue Increases 13% Year-Over-Year to $179.9 Million
|
- |
Company Signs Multiple Contracts in 2020, Including 10-Year, Billion Dollar + Contracts with TSA PreCheck and Centers for Medicare and Medicaid Services
|
- |
Strengthens Balance Sheet with $292.6 Million in IPO Gross Proceeds and Elimination of Debt in the Fourth Quarter
|
- |
Company Issues Full Year and First Quarter 2021 Guidance
|
|
• |
Revenue: Total revenue was $44.9 million, compared to $46.5 million in the fourth
quarter of 2019. The expected decline in revenue was due to the ramping down of the U.S. Census contract during the fourth quarter of 2020.
|
• |
Gross Profit: Gross profit was $16.0 million, compared to $17.0 million in the fourth
quarter of 2019.
|
• |
Net Income (Loss): Net income (loss) was $3.9 million, compared to $(3.5) million in the
fourth quarter of 2019.
|
• |
Enterprise EBITDA: Enterprise EBITDA was $5.4 million, compared to $2.5 million in the
fourth quarter of 2019.
|
• |
Adjusted EBITDA: Adjusted EBITDA was $(2.6) million, compared to $2.5 million in the
fourth quarter of 2019.
|
• |
Net earnings per share attributable to Telos Corporation, diluted: $0.08.
|
• |
Weighted-average shares of common stock outstanding: 51.3 million (which reflects
reverse stock split and the IPO).
|
• |
Revenue: Total revenue increased 13% to $179.9 million, compared to $159.2 million in
2019.
|
• |
Gross Profit: Gross profit increased 19% to $62.4 million, compared to $52.3 million in
2019.
|
• |
Net Income (Loss): Net income was $1.7 million, compared to net loss of $(6.4) million
in 2019.
|
• |
Enterprise EBITDA: Enterprise EBITDA was $19.4 million, compared to $10.0 million in
2019.
|
• |
Adjusted EBITDA: Adjusted EBITDA was $11.4 million, compared to $10.0 million in 2019.
|
• |
Cash and Cash Equivalents: Cash and cash equivalents were $106.0 million as of December
31, 2020, compared to $6.8 million as of December 31, 2019.
|
• |
Net earnings per share attributable to Telos Corporation, diluted: $0.04.
|
• |
Weighted-average shares of common stock outstanding: 42.9 million (which reflects
reverse stock split and the IPO).
|
• |
Outstanding shares of Common Stock as of December 31, 2020: 64,625,071.
|
|
• |
The Federal Bureau of Investigation (FBI) awarded Telos a contract for enterprise-wide risk management valued at $13.5 million. Xacta has been successfully deployed across the
federal government including the Intelligence Community, multiple civilian agencies and the Department of Defense, and the Company is proud to extend this work to the FBI.
|
• |
Under a contract with the U.S. Census Bureau to vet 2020 Census enumerators, in partnership with Office Depot, Telos quickly established a network of 1,100 processing centers,
supporting the objectives of the Census Bureau with the Company’s IDTrust360® solution on a national scale. As a result, the Company was able to process over 1 million enumerators over four months during the height of COVID-19.
|
• |
The Transportation Security Administration (TSA) selected Telos to provide TSA PreCheck™ enrollment services. Under the terms of the 10-year contract anticipated to generate
revenue in excess of $1.5 billion over time, IDTrust360 will collect application materials, biometric data, and fees from each applicant, and will provide all necessary information to TSA for adjudication.
|
• |
The Centers for Medicare and Medicaid Services awarded Telos a 10-year contract in 2020. Under this $2 billion ceiling contract, one of the task orders provides for the use of
IDTrust360 to vet approximately 1.5 million healthcare providers annually.
|
• |
Telos Ghost was awarded a classified contract to provide the underlying security enabling the customer to complete their missions on the public internet and dark web through
misattribution.
|
• |
Other significant contracts in 2020 include a $66.4 million award with the U.S. Air Force and a $26.6 million award with the U.S. Army, both within the Company’s Secure Networks
business. Telos also received a $15.6 million award with DISA for their official messaging solution, AMHS.
|
• |
Telos has formed strategic partnerships and alliances over the year both domestically and globally, including a partnership with ST Engineering, a global technology, defense and
engineering leader from Singapore that extends the availability of Telos Ghost and Xacta into Asia and the Middle East.
|
• |
Xacta has integrated with leading security solutions like Splunk, which is used to import security data into Xacta to enable critical security risk and compliance management
functions.
|
• |
The Company continued to advance Xacta’s multi-cloud focus by integrating with Microsoft® Azure and expanding support for Amazon Web Services (AWS).
|
• |
To usher in a new era of growth and expansion, Telos welcomed new members to the Company’s board of directors and advisory board, including noted entrepreneur and investment guru
Fred Schaufeld; Presidential Medal of Freedom recipient and Tragedy Assistance Program for Survivors Founder and President, Bonnie Carroll; and the longest-serving Director of the NSA and the first commander of USCYBERCOM, GEN (retired)
Keith Alexander.
|
|
• |
Revenue in the range of $49 million to $52 million.
|
• |
Adjusted EBITDA in the range of $(1.7) million to $(1.9) million.
|
• |
Revenue in the range of $283 million to $295 million, an improvement of 57% to 64% compared to 2020.
|
• |
Adjusted EBITDA in the range of $33 million to $36 million, an improvement of 190% to 216% compared to 2020.
|
|
|
|
|
Years Ended December 31,
|
||||||||||||
2020
|
2019
|
2018
|
||||||||||
Revenue
|
||||||||||||
Services
|
$
|
161,180
|
$
|
143,581
|
$
|
120,990
|
||||||
Products
|
18,737
|
15,637
|
17,026
|
|||||||||
179,917
|
159,218
|
138,016
|
||||||||||
Costs and expenses
|
||||||||||||
Cost of sales – Services
|
106,969
|
98,772
|
76,857
|
|||||||||
Cost of sales – Products
|
10,528
|
8,102
|
8,097
|
|||||||||
117,497
|
106,874
|
84,954
|
||||||||||
Selling, general and administrative expenses
|
||||||||||||
Sales and marketing
|
6,176
|
5,951
|
6,014
|
|||||||||
Research and development
|
14,243
|
10,647
|
8,755
|
|||||||||
General and administrative
|
41,704
|
30,721
|
29,279
|
|||||||||
62,123
|
47,319
|
44,048
|
||||||||||
Operating income
|
297
|
5,025
|
9,014
|
|||||||||
Other income (expenses)
|
||||||||||||
Gain on redemption of public preferred stock
|
14,012
|
----
|
----
|
|||||||||
Non-operating (expense) income
|
(255
|
)
|
201
|
12
|
||||||||
Interest expense
|
(7,259
|
)
|
(7,467
|
)
|
(7,258
|
)
|
||||||
Income (loss) before income taxes
|
6,795
|
(2,241
|
)
|
1,768
|
||||||||
Benefit from (provision for) income taxes
|
46
|
104
|
(31
|
)
|
||||||||
Net income (loss)
|
6,841
|
(2,137
|
)
|
1,737
|
||||||||
Less: Net income attributable to non-controlling interest
|
(5,154
|
)
|
(4,264
|
)
|
(3,377
|
)
|
||||||
Net income (loss) attributable to Telos Corporation
|
$
|
1,687
|
$
|
(6,401
|
)
|
$
|
(1,640
|
)
|
||||
Net earnings (loss) per share attributable to Telos Corporation, basic
|
$
|
0.04
|
$
|
(0.17
|
)
|
$
|
(0.04
|
)
|
||||
Net earnings (loss) per share attributable to Telos Corporation, diluted
|
$
|
0.04
|
$
|
(0.17
|
)
|
$
|
(0.04
|
)
|
||||
Weighted-average shares of common stock outstanding, basic
|
41,642
|
37,729
|
36,762
|
|||||||||
Weighted-average shares of common stock outstanding, diluted
|
42,877
|
37,729
|
36,762
|
|
December 31,
|
||||||||
2020
|
2019
|
|||||||
Current assets
|
||||||||
Cash and cash equivalents
|
$
|
106,045
|
$
|
6,751
|
||||
Accounts receivable, net of reserve of $308 and $720, respectively
|
30,913
|
27,942
|
||||||
Inventories, net of obsolescence reserve of $851 and $860, respectively
|
3,311
|
1,965
|
||||||
Prepaid expenses
|
3,059
|
1,717
|
||||||
Deferred program expenses
|
5
|
673
|
||||||
Other current assets
|
781
|
1,197
|
||||||
Total current assets
|
144,114
|
40,245
|
||||||
Property and equipment
|
||||||||
Furniture, equipment and capitalized software development costs
|
25,827
|
18,709
|
||||||
Leasehold improvements
|
2,669
|
2,536
|
||||||
Property and equipment under finance leases
|
30,792
|
30,792
|
||||||
59,288
|
52,037
|
|||||||
Accumulated depreciation and amortization
|
(36,891
|
)
|
(32,470
|
)
|
||||
22,397
|
19,567
|
|||||||
Operating lease right-of-use assets
|
1,464
|
1,979
|
||||||
Goodwill
|
14,916
|
14,916
|
||||||
Other assets
|
926
|
985
|
||||||
Total assets
|
$
|
183,817
|
$
|
77,692
|
|
December 31,
|
||||||||
2020
|
2019
|
|||||||
Current liabilities
|
||||||||
Accounts payable and other accrued liabilities
|
$
|
20,899
|
$
|
15,050
|
||||
Accrued compensation and benefits
|
8,474
|
12,187
|
||||||
Contract liabilities
|
5,654
|
6,337
|
||||||
Finance lease obligations – short-term
|
1,339
|
1,224
|
||||||
Operating lease obligations – short-term
|
677
|
602
|
||||||
Other current liabilities
|
1,903
|
1,903
|
||||||
Total current liabilities
|
38,946
|
37,303
|
||||||
Senior term loan, net of unamortized discount and issuance costs
|
----
|
16,335
|
||||||
Subordinated debt
|
----
|
2,927
|
||||||
Finance lease obligations – long-term
|
14,301
|
15,641
|
||||||
Operating lease obligations – long-term
|
941
|
1,553
|
||||||
Deferred income taxes
|
652
|
621
|
||||||
Public preferred stock
|
----
|
139,210
|
||||||
Other liabilities
|
1,873
|
724
|
||||||
Total liabilities
|
56,713
|
214,314
|
||||||
Commitments and contingencies
|
||||||||
Stockholders’ equity (deficit)
|
||||||||
Telos stockholders’ equity (deficit)
|
||||||||
Common stock, $0.001 par value, 250,000,000 shares authorized, 64,625,071 shares issued and outstanding as of
December 31, 2020
|
103
|
----
|
||||||
Class A common stock, no par value, 50,000,000 shares authorized, 35,826,200 shares issued and outstanding as
of December 31, 2019
|
----
|
65
|
||||||
Class B common stock, no par value, 5,000,000 shares authorized, 3,204,293 shares issued and outstanding as of
December 31, 2019
|
----
|
13
|
||||||
Additional paid-in capital
|
270,800
|
4,310
|
||||||
Accumulated other comprehensive income
|
44
|
6
|
||||||
Accumulated deficit
|
(143,843
|
)
|
(145,530
|
)
|
||||
Total Telos stockholders’ equity (deficit)
|
127,104
|
(141,136
|
)
|
|||||
Non-controlling interest in subsidiary
|
----
|
4,514
|
||||||
Total stockholders’ equity (deficit)
|
127,104
|
(136,622
|
)
|
|||||
Total liabilities and stockholders’ equity (deficit)
|
$
|
183,817
|
$
|
77,692
|
|
Years Ended December 31,
|
||||||||||||
2020
|
2019
|
2018
|
||||||||||
Operating activities:
|
||||||||||||
Net income (loss)
|
$
|
6,841
|
$
|
(2,137
|
)
|
$
|
1,737
|
|||||
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:
|
||||||||||||
Gain on redemption of public preferred stock
|
(14,012
|
)
|
----
|
----
|
||||||||
Net loss on early extinguishment of debt and other transactions
|
275
|
----
|
----
|
|||||||||
Stock-based compensation
|
4
|
----
|
----
|
|||||||||
Dividends from preferred stock recorded as interest expense
|
3,384
|
3,823
|
3,822
|
|||||||||
Depreciation and amortization
|
5,353
|
4,972
|
3,028
|
|||||||||
Provision for inventory obsolescence
|
(1
|
)
|
376
|
30
|
||||||||
(Benefit) provision for doubtful accounts receivable
|
(412
|
)
|
414
|
(105
|
)
|
|||||||
Provision for doubtful non-trade receivables
|
569
|
----
|
----
|
|||||||||
Amortization of debt issuance costs
|
978
|
461
|
198
|
|||||||||
Deferred income tax provision (benefit)
|
31
|
(197
|
)
|
77
|
||||||||
Loss on disposal of fixed assets
|
1
|
15
|
3
|
|||||||||
Changes in assets and liabilities:
|
||||||||||||
(Increase) decrease in accounts receivable
|
(2,559
|
)
|
6,186
|
(9,917
|
)
|
|||||||
(Increase) decrease in inventories
|
(1,345
|
)
|
2,048
|
9,101
|
||||||||
Decrease (increase) in deferred program expenses
|
668
|
(429
|
)
|
1,828
|
||||||||
Increase in prepaid expenses, other current assets and other assets
|
(1,606
|
)
|
(3,576
|
)
|
(465
|
)
|
||||||
Increase (decrease) in accounts payable and other accrued payables
|
3,413
|
(6,730
|
)
|
(3,914
|
)
|
|||||||
(Decrease) increase in accrued compensation and benefits
|
(3,713
|
)
|
3,105
|
1,626
|
||||||||
(Decrease) increase in contract liabilities
|
(683
|
)
|
1,106
|
(960
|
)
|
|||||||
Increase in other current liabilities and other liabilities
|
710
|
2,379
|
179
|
|||||||||
Cash (used in) provided by operating activities
|
(2,104
|
)
|
11,816
|
6,268
|
||||||||
Investing activities:
|
||||||||||||
Capitalized software development costs
|
(6,681
|
)
|
(2,442
|
)
|
(1,649
|
)
|
||||||
Purchases of property and equipment
|
(780
|
)
|
(4,090
|
)
|
(2,465
|
)
|
||||||
Cash used in investing activities
|
(7,461
|
)
|
(6,532
|
)
|
(4,114
|
)
|
||||||
Financing activities:
|
||||||||||||
Proceeds from initial public offering
|
272,813
|
----
|
----
|
|||||||||
Redemption of public preferred stock
|
(108,878
|
)
|
----
|
----
|
||||||||
Purchase of Telos ID membership interest
|
(30,000
|
)
|
----
|
----
|
||||||||
Payment of senior term loan
|
(17,351
|
)
|
----
|
----
|
||||||||
Payment of subordinated debt
|
(3,657
|
)
|
----
|
----
|
||||||||
Proceeds from senior term loan
|
----
|
4,881
|
----
|
|||||||||
Payments under finance lease obligations
|
(1,225
|
)
|
(1,115
|
)
|
(1,013
|
)
|
||||||
Amendment fee paid to lender
|
(100
|
)
|
----
|
----
|
||||||||
Distributions to Telos ID Class B member – non-controlling interest
|
(2,743
|
)
|
(2,371
|
)
|
(1,669
|
)
|
||||||
Cash provided by (used in) financing activities
|
108,859
|
1,395
|
(2,682
|
)
|
||||||||
Increase (decrease) in cash and cash equivalents
|
99,294
|
6,679
|
(528
|
)
|
||||||||
Cash and cash equivalents, beginning of the year
|
6,751
|
72
|
600
|
|||||||||
Cash and cash equivalents, end of year
|
$
|
106,045
|
$
|
6,751
|
$
|
72
|
|
Enterprise EBITDA and Adjusted EBITDA (Unaudited)
|
Three Months Ended
December 31,
|
Years Ended December 31,
|
||||||||||||||
2020
|
2019
|
2020
|
2019
|
|||||||||||||
(amounts in thousands)
|
||||||||||||||||
Net income (loss) attributable to Telos Corporation
|
$
|
3,865
|
$
|
(3,480
|
)
|
$
|
1,687
|
$
|
(6,401
|
)
|
||||||
Net (loss) income attributable to non-controlling interest
|
(1,130
|
)
|
2,559
|
5,154
|
4,264
|
|||||||||||
Non-operating (expense) income
|
(6
|
)
|
(6
|
)
|
(20
|
)
|
(201
|
)
|
||||||||
Interest expense
|
1,233
|
1,997
|
7,259
|
7,467
|
||||||||||||
Provision (benefit) for income taxes
|
90
|
83
|
(46
|
)
|
(104
|
)
|
||||||||||
Depreciation and amortization
|
1,335
|
1,363
|
5,353
|
4,972
|
||||||||||||
Enterprise EBITDA
|
5,387
|
2,516
|
19,387
|
9,997
|
||||||||||||
Transaction related gains/losses/expenses (1)
|
(8,007
|
)
|
----
|
(8,007
|
)
|
----
|
||||||||||
Stock-based compensation expense
|
----
|
----
|
4
|
----
|
||||||||||||
Adjusted EBITDA
|
$
|
(2,620
|
)
|
$
|
2,516
|
$
|
11,384
|
$
|
9,997
|